Inhibitory effects and structural analysis of drug candidate PF-07817883 against coronaviral main proteases (Mpro) and SARS-CoV-2 Mpro mutants.

ibuzatrelvir (PF-07817883) - Pfizer

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42292328

Bing Fan; Haihai Jiang; Jian Li; Weiwei Wang; Xuelan Zhou; Zhenyu Zhao

Jun 16, 2026